Public Employees Retirement Association of Colorado maintained its position in Masimo Corporation (NASDAQ:MASI) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,048 shares of the medical equipment provider’s stock at the end of the second quarter. Public Employees Retirement Association of Colorado’s holdings in Masimo Corporation were worth $916,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. boosted its position in Masimo Corporation by 4,676.3% in the first quarter. BlackRock Inc. now owns 7,364,235 shares of the medical equipment provider’s stock worth $686,789,000 after buying an additional 7,210,051 shares in the last quarter. Vanguard Group Inc. boosted its position in Masimo Corporation by 5.9% in the first quarter. Vanguard Group Inc. now owns 4,617,633 shares of the medical equipment provider’s stock worth $430,641,000 after buying an additional 258,719 shares in the last quarter. Acadian Asset Management LLC boosted its position in Masimo Corporation by 28.0% in the second quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after buying an additional 392,410 shares in the last quarter. State Street Corp boosted its position in Masimo Corporation by 42.8% in the first quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock worth $130,704,000 after buying an additional 419,767 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Masimo Corporation by 36.9% in the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock worth $60,175,000 after buying an additional 173,931 shares in the last quarter. 84.14% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Masimo Corporation (NASDAQ:MASI) opened at 86.45 on Thursday. The stock has a market cap of $4.49 billion, a price-to-earnings ratio of 14.17 and a beta of 0.80. Masimo Corporation has a one year low of $53.78 and a one year high of $104.71. The company has a 50 day moving average price of $91.62 and a 200-day moving average price of $90.27.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.57 earnings per share. Equities analysts predict that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/17/public-employees-retirement-association-of-colorado-maintains-stake-in-masimo-corporation-masi.html.

MASI has been the topic of a number of analyst reports. BidaskClub cut Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 target price (up previously from $105.00) on shares of Masimo Corporation in a research note on Thursday, August 3rd. Wedbush reaffirmed an “outperform” rating and set a $112.00 target price on shares of Masimo Corporation in a research note on Monday, May 22nd. Finally, BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Monday. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $95.00.

In other Masimo Corporation news, insider Jon Coleman sold 25,000 shares of the business’s stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total value of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares in the company, valued at $3,139,597.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Sanford Fitch sold 14,000 shares of the business’s stock in a transaction on Thursday, June 29th. The stock was sold at an average price of $92.06, for a total transaction of $1,288,840.00. Following the completion of the transaction, the director now owns 90,249 shares of the company’s stock, valued at approximately $8,308,322.94. The disclosure for this sale can be found here. In the last 90 days, insiders sold 115,000 shares of company stock valued at $10,773,180. Insiders own 16.60% of the company’s stock.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.